Tesaro's Series A Round

Tesaro raised a round of funding on May 05, 2010. Investors include New Enterprise Associates.

Tesaro is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to identify, acquire, and develop promising drug candidates; and to com…

Articles about Tesaro's Series A Round: